Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
Authors
Woodward Mark
Anderson S.
Heald A.
Hutchings D.
Rutter M.
Kirby M.
Hackett G.
Trafford A.
Rahimi K
Type of Publication
Journal Article
ISBN Number
1468-201X (Electronic)<br/>1355-6037 (Linking)
